TNFSF13B and COVID-19: Besides, we found significantly higher BAFF levels in the severe COVID-19 group than the non-severe group, indicating robust activation of B cell response associated with BAFF in severe COVID-19 patients when corresponding to overall higher antibody responses in severe group.